1. COMPARISON OF OUTCOMES BETWEEN PATIENTS WITH MYC REARRANGED DLBCL AND DOUBLE/ TRIPLE HIT HIGH‐GRADE B CELL LYMPHOMA: A PAN‐LONDON RETROSPECTIVE REVIEW. (12th June 2019) Authors: El‐Sharkawi, D.; Sharma, S.; Cook, L.; Hanley, B.; Johnston, R.; Arasaretnam, A.; Lazana, I.; Greaves, P.; Parkinson, A.; Peng, Y.; Kassam, S.; Peacock, V.; Kaczmarski, R.; Bower, M.; Cheung, B.; De Lord, C.; Cross, M.; Vroobel, K.; Wotherspoon, A.; Aldridge, F. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 348 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1433: USE OF A FOAMY-VIRUS VECTOR SYSTEM TO PRODUCE AN 'OFF-THE-SHELF' ANTI-CD19 CAR T CELL PRODUCT. (23rd June 2022) Authors: Lazana, I.; Simantirakis, E.; Daniil, M.; Tsironis, I.; Vassilopoulos, G. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1316 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗